THURSDAY, Aug. 20, 2026 — An experimental vaccine kept melanoma from returning or spreading in people at high risk of the skin cancer coming back, drugmakers Moderna and Merck announced Wednesday.
The vaccine is built for one patient at a…
Blog
Leave a Reply